News Focus
News Focus
Followers 62
Posts 2098
Boards Moderated 0
Alias Born 05/09/2020

Re: humble howard post# 86252

Monday, 06/22/2020 11:34:43 AM

Monday, June 22, 2020 11:34:43 AM

Post# of 236721
Very true. The crystal ball on successful proof of additional conditions is a bit murky right now. From a statistical point of view, I'm figuring at least 50% of the "Cancer-22" trials go with Leronlimab as new SOC. The NASH, mTNBC, and GvHD are almost slam dunk with no real competition out there.

The others???...hopefully the crystal ball with begin to clear up when the SP goes north of $25.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News